37 results on '"Kissinger, Charles R."'
Search Results
2. Molecular Modeling and Structure-Based Design of Direct Calcineurin Inhibitors
3. Crystal Structure of Human ABAD/HSD10 with a Bound Inhibitor: Implications for Design of Alzheimer's Disease Therapeutics
4. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex
5. Intrinsically disordered protein
6. Interaction of a novel GDP exchange inhibitor with the Ras protein
7. Discovery of tricyclic 5,6-dihydro-1 H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase
8. 5,5′- and 6,6′-Dialkyl-5,6-dihydro-1 H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase
9. Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ 6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2 H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents
10. Hexahydro-pyrrolo- and hexahydro-1 H-pyrido[1,2- b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
11. 4-(1,1-Dioxo-1,4-dihydro-1λ 6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2 H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymerase
12. Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[ b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase
13. Pyrrolo[1,2- b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
14. Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ 6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2 H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7′-substituents and initial pharmacokinetic assessments
15. Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ 6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2 H-pyridazin-3-ones. Part 1: Exploration of 7′-substitution of benzothiadiazine
16. Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′ λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2 H-pyridazin-3-ones. Part 2: Variation of the 2- and 6-pyridazinone substituents
17. Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase
18. 5,5′- and 6,6′-Dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase
19. Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents
20. Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
21. 4-(1,1-Dioxo-1,4-dihydro-1λ6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymerase
22. Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase
23. Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7′-substituents and initial pharmacokinetic assessments
24. Structure of hepatitis C virus IRES subdomain IIa
25. Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: Exploration of 7′-substitution of benzothiadiazine
26. Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 2: Variation of the 2- and 6-pyridazinone substituents
27. Molecular replacement by evolutionary search
28. Rapid automated molecular replacement by evolutionary search
29. DISORDER IN PROTEIN STRUCTURE AND FUNCTION
30. Structure-based design of novel calcineurin (PP2B) inhibitors
31. Protein serine/threonine phosphatases
32. Structure-Based Design of Novel, Urea-Containing FKBP12 Inhibitors
33. Structural studies of the engrailed homeodomain
34. Refined crystal structure of ferredoxin II from Desulfovibrio gigas at 1·7 Å
35. Crystal structure of an engrailed homeodomain-DNA complex at 2.8 Å resolution: A framework for understanding homeodomain-DNA interactions
36. Crystallization and preliminary X-ray diffraction studies of the engrailed homeodomain and of an engrailed homeodomain/DNA complex
37. Structure of the 3 iron-4 sulfur cluster in Desulfovibrio gigas ferredoxin II
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.